- Case-Based Modules
- Initial Evaluation
- Dermatologic Manifestations
- Oral Manifestations
- OIs: Prophylaxis
- OIs: Treatment
- Antiretroviral Rx
- Antiretroviral Rx: Resistance
- Antiretroviral Rx: Adverse Effects
- Drug-Drug Interactions
- Postexposure Prophylaxis
- Perinatal Transmission
- Special Populations
- Prevention for Positives
- Challenging Unknowns
- Resource-Limited Settings
- Interactive Tutorials
- Routine HIV Screening
- Oraquick Advance Rapid HIV Test
- HIV Integration
- This program is funded through Health Resources and Services Administration, US Department of Health and Human Services.
Antiretroviral Rx
Question | Discussion | References | CME Credit
Updated August 24, 2011
Case 2: Antiretroviral Regimens
| Author: | David H. Spach, MD |
- Identify the key enzymes involved in the HIV life cycle.
- List the preferred antiretroviral regimens as recommended in the DHHS antiretroviral therapy guidelines for persons with chronic HIV infection.
A 36-year-old woman has recently been diagnosed with HIV infection. Her initial laboratory studies show a CD4 count of 100 cells/mm3 and HIV RNA of 87,500 copies/ml. Repeat laboratory studies performed one month later show similar results. She has not had any HIV-related complications history. Her physical examination is normal. She is very interested in starting antiretroviral therapy. Her only medication that she takes is trimethoprim-sulfamethoxazole (Bactrim, Septra).
According to the January 2011 DHHS Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents, which of the following statements is TRUE regarding initial antiretroviral therapy?
Copyright © 2004-2011 University of Washington